Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.

Kutty Selva, Nandakumar LU ; Bäcklund, Johan LU ; Vestberg, Mikael LU and Holmdahl, Rikard LU (2004) In Arthritis Research and Therapy 6(6). p.544-550
Abstract
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have a role in enhancing arthritis development at the effector level of arthritis pathogenesis, we established a T cell line reactive with CII. This T cell line was oligoclonal and responded to different post-translational forms of the major CII epitope at... (More)
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have a role in enhancing arthritis development at the effector level of arthritis pathogenesis, we established a T cell line reactive with CII. This T cell line was oligoclonal and responded to different post-translational forms of the major CII epitope at position 260–270 bound to the Aq class II molecule. Importantly, it cross-reacted with the mouse peptide although it is bound with lower affinity to the Aq molecule than the corresponding rat peptide. The T cell line could not induce clinical arthritis per se in Aq-expressing mice even if these mice expressed the major heterologous CII epitope in cartilage, as in the transgenic MMC (mutated mouse collagen) mouse. However, a combined treatment with anti-CII monoclonal antibodies and CII-reactive T cells enhanced the progression of severe arthritis. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
T cells, monoclonal antibodies, collagen type II, arthritis, B cells
in
Arthritis Research and Therapy
volume
6
issue
6
pages
544 - 550
publisher
BioMed Central (BMC)
external identifiers
  • wos:000225160100012
  • pmid:15535832
  • scopus:17444405097
  • pmid:15535832
ISSN
1478-6362
DOI
10.1186/ar1217
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Medical Inflammation Research (013212019)
id
2cdf61c7-4963-4f66-973f-0d9932803748 (old id 130902)
date added to LUP
2016-04-01 11:40:42
date last changed
2022-04-12 23:35:26
@article{2cdf61c7-4963-4f66-973f-0d9932803748,
  abstract     = {{Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have a role in enhancing arthritis development at the effector level of arthritis pathogenesis, we established a T cell line reactive with CII. This T cell line was oligoclonal and responded to different post-translational forms of the major CII epitope at position 260–270 bound to the Aq class II molecule. Importantly, it cross-reacted with the mouse peptide although it is bound with lower affinity to the Aq molecule than the corresponding rat peptide. The T cell line could not induce clinical arthritis per se in Aq-expressing mice even if these mice expressed the major heterologous CII epitope in cartilage, as in the transgenic MMC (mutated mouse collagen) mouse. However, a combined treatment with anti-CII monoclonal antibodies and CII-reactive T cells enhanced the progression of severe arthritis.}},
  author       = {{Kutty Selva, Nandakumar and Bäcklund, Johan and Vestberg, Mikael and Holmdahl, Rikard}},
  issn         = {{1478-6362}},
  keywords     = {{T cells; monoclonal antibodies; collagen type II; arthritis; B cells}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{544--550}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Arthritis Research and Therapy}},
  title        = {{Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.}},
  url          = {{https://lup.lub.lu.se/search/files/2591053/624174.pdf}},
  doi          = {{10.1186/ar1217}},
  volume       = {{6}},
  year         = {{2004}},
}